233 related articles for article (PubMed ID: 32911634)
1. Pro-Aging Effects of Xanthine Oxidoreductase Products.
Battelli MG; Bortolotti M; Bolognesi A; Polito L
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32911634
[TBL] [Abstract][Full Text] [Related]
2. The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors.
Liu N; Xu H; Sun Q; Yu X; Chen W; Wei H; Jiang J; Xu Y; Lu W
Oxid Med Cell Longev; 2021; 2021():1470380. PubMed ID: 33854690
[TBL] [Abstract][Full Text] [Related]
3. The double faced role of xanthine oxidoreductase in cancer.
Chen MM; Meng LH
Acta Pharmacol Sin; 2022 Jul; 43(7):1623-1632. PubMed ID: 34811515
[TBL] [Abstract][Full Text] [Related]
4. Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry.
Kurajoh M; Fukumoto S; Yoshida S; Akari S; Murase T; Nakamura T; Ishii H; Yoshida H; Nagata Y; Morioka T; Mori K; Imanishi Y; Hirata K; Emoto M
Sci Rep; 2021 Apr; 11(1):7378. PubMed ID: 33795813
[TBL] [Abstract][Full Text] [Related]
5. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
Battelli MG; Bortolotti M; Polito L; Bolognesi A
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.
Chen C; Lü JM; Yao Q
Med Sci Monit; 2016 Jul; 22():2501-12. PubMed ID: 27423335
[TBL] [Abstract][Full Text] [Related]
7. Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension.
Oliveira-Paula GH; Pinheiro LC; Guimaraes DA; Tella SO; Blanco AL; Angelis CD; Schechter AN; Tanus-Santos JE
Redox Biol; 2016 Aug; 8():398-406. PubMed ID: 27078869
[TBL] [Abstract][Full Text] [Related]
8. Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?
Schuchardt M; Herrmann J; Tolle M; van der Giet M
Curr Pharm Des; 2017; 23(23):3391-3404. PubMed ID: 28413972
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidoreductase: A leading actor in cardiovascular disease drama.
Polito L; Bortolotti M; Battelli MG; Bolognesi A
Redox Biol; 2021 Nov; 48():102195. PubMed ID: 34844041
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase.
Battelli MG; Bortolotti M; Polito L; Bolognesi A
Redox Biol; 2019 Feb; 21():101070. PubMed ID: 30576922
[TBL] [Abstract][Full Text] [Related]
11. Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry.
Kurajoh M; Fukumoto S; Akari S; Murase T; Nakamura T; Ihara Y; Imai T; Nagata Y; Morioka T; Mori K; Imanishi Y; Watanabe T; Emoto M
Int J Cardiol Heart Vasc; 2023 Oct; 48():101264. PubMed ID: 37680549
[TBL] [Abstract][Full Text] [Related]
12. Unexpected high plasma xanthine oxidoreductase activity in female subjects with low levels of uric acid.
Furuhashi M; Mori K; Tanaka M; Maeda T; Matsumoto M; Murase T; Nakamura T; Koyama M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Endocr J; 2018 Nov; 65(11):1083-1092. PubMed ID: 30068899
[TBL] [Abstract][Full Text] [Related]
13. Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry.
Yoshida S; Kurajoh M; Fukumoto S; Murase T; Nakamura T; Yoshida H; Hirata K; Inaba M; Emoto M
Sci Rep; 2020 Mar; 10(1):4437. PubMed ID: 32157204
[TBL] [Abstract][Full Text] [Related]
14. Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects.
Battelli MG; Polito L; Bortolotti M; Bolognesi A
Oxid Med Cell Longev; 2016; 2016():3527579. PubMed ID: 26823950
[TBL] [Abstract][Full Text] [Related]
15. Human Plasma Xanthine Oxidoreductase Activity in Cardiovascular Disease: Evidence from a Population-Based Study.
Kotozaki Y; Satoh M; Nasu T; Tanno K; Tanaka F; Sasaki M
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979733
[TBL] [Abstract][Full Text] [Related]
16. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
Peleli M; Zollbrecht C; Montenegro MF; Hezel M; Zhong J; Persson EG; Holmdahl R; Weitzberg E; Lundberg JO; Carlström M
Free Radic Biol Med; 2016 Oct; 99():472-484. PubMed ID: 27609225
[TBL] [Abstract][Full Text] [Related]
17. Xanthine Oxidoreductase Function Contributes to Normal Wound Healing.
Madigan MC; McEnaney RM; Shukla AJ; Hong G; Kelley EE; Tarpey MM; Gladwin M; Zuckerbraun BS; Tzeng E
Mol Med; 2015 Apr; 21(1):313-22. PubMed ID: 25879627
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling.
Agarwal A; Banerjee A; Banerjee UC
Crit Rev Biotechnol; 2011 Sep; 31(3):264-80. PubMed ID: 21774633
[TBL] [Abstract][Full Text] [Related]
19. Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.
Kelley EE
Arch Toxicol; 2015 Aug; 89(8):1193-207. PubMed ID: 25995007
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme.
Battelli MG; Bolognesi A; Polito L
Biochim Biophys Acta; 2014 Sep; 1842(9):1502-17. PubMed ID: 24882753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
